Related Party Transactions and Arrangements

6 Months Ended

Sep. 30, 2020

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS AND ARRANGEMENTS

Note 20 – RELATED PARTY TRANSACTIONS AND ARRANGEMENTS

Amounts payable to related parties are summarized as follows:

	September 30, 2020		March 31, 2020
Due to a director and CEO (1) :		574,103		490,218

(1) Due to foreign exchange restrictions, the Company’s director and CEO, Mr. Lei Liu personally lent U.S. dollars to the Company to facilitate its payments of expenses in the United States.

The Company leases from Mr. Lei Liu a retail space; the lease expires in September 2020. Rent expenses totaled $6,691 and $6,599 for the three months ended September 30, 2020 and 2019, respectively. Rent expenses totaled $13,223 and $13,384 for the six months ended September 30, 2020 and 2019, respectively. The amounts owed under the lease for the six months ended September 30, 2020 and 2019 were not paid to Mr. Liu as of September 30, 2020.

On April 28, 2018, 10% of Jiuxin Medicine was sold to Hangzhou Kangzhou Biotech Co. Ltd. for a total proceeds of approximately $75,643 (RMB507, 760). Mr. Lei Liu owns 51% of Hangzhou Kangzhou Biotech Co. Ltd.